Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury

Takaharu Ichimura1, Cheng Chieh Hung, Soon Ae Yang

  • 1Medical Services, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. tichimura@partners.org

Insights

Kidney Injury Molecule-1 (Kim-1) shows increased expression and urinary presence after exposure to various nephrotoxicants. This suggests Kim-1 may serve as a general biomarker for kidney tubular injury and repair.

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Toxicology

Background:

  • Nephrotoxicity from medical treatments, environmental factors, and workplace exposures is a significant clinical concern.
  • Current biomarkers for kidney injury often lack sensitivity and specificity for epithelial cell damage.
  • Kidney Injury Molecule-1 (Kim-1) is a protein upregulated in rodent and human kidneys following ischemic injury.

Purpose of the Study:

  • To investigate the utility of Kim-1 as a biomarker for diverse types of nephrotoxic renal injury.
  • To analyze Kim-1 expression in kidney tissue and urine following exposure to specific nephrotoxicants.

Main Methods:

  • Rats were exposed to three distinct nephrotoxicants: S-(1,1,2,2-tetrafluoroethyl)-l-cysteine (TFEC), folic acid, and cisplatin.
  • Immunoblotting was used to confirm increases in Kim-1 expression.
  • Immunofluorescence localized Kim-1 protein within kidney tissue.
  • Urinary Kim-1 levels were measured.

Main Results:

  • Marked increases in Kim-1 expression were observed in kidney tissue across all three nephrotoxicant models.
  • Kim-1 protein was localized to proximal tubule epithelial cells.
  • Urinary Kim-1 protein was detected in rats treated with TFEC, folic acid, and cisplatin.
  • Urinary Kim-1 was detected before significant increases in serum creatinine in folic acid and cisplatin models.

Conclusions:

  • Upregulation of Kim-1 expression and its presence in urine indicate its potential as a general biomarker for kidney tubular injury.
  • Kim-1 detection in urine may precede traditional markers of renal dysfunction, offering earlier diagnostic insights.
  • These findings support Kim-1's role in monitoring kidney damage and repair processes induced by various nephrotoxic insults.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...